Wuhan YZY Biopharma Co., Ltd.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody	Malignant Ascites	Active, not recruiting	Phase 3	2026-08-20		NCT06432296
A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC	Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 1 / Phase 2	2026-07-08		NCT05543330

Clinical trials